VERBIO Vereinigte BioEnergie AG
Deutsche BörseTotal Valuation
VERBIO Vereinigte BioEnergie AG carries a market capitalization of 1.95B, placing it among publicly traded companies globally. Its enterprise value stands at 3.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.95B |
| Enterprise Value | 3.18B |
Share Statistics
VERBIO Vereinigte BioEnergie AG currently has 63.72M shares outstanding.
| Shares Outstanding | 63.72M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1.71, and the price-to-book ratio stands at 10.69.
| PE Ratio | N/A |
| PS Ratio | 1.71 |
| PB Ratio | 10.69 |
| P/TBV Ratio | 3.95 |
| P/FCF Ratio | 13.69 |
| P/OCF Ratio | 24.91 |
Enterprise Valuation
| EV / Sales | 1.79 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 12.85 |
Financial Position
VERBIO Vereinigte BioEnergie AG maintains a current ratio of 1.91, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 29.60, indicating elevated leverage, while an interest coverage ratio of -3.46 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.91 |
| Quick Ratio | 0.27 |
| Debt / Equity | 29.60 |
| Debt / EBITDA | -3.75 |
| Interest Coverage | -3.46 |
Financial Efficiency
| Return on Equity (ROE) | -23.40 |
| Return on Assets (ROA) | -5.60 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -18.34 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.45 |
Taxes
Over the trailing twelve months, VERBIO Vereinigte BioEnergie AG has paid 24.73M in income taxes, reflecting an effective tax rate of 119.44.
| Income Tax | 24.73M |
| Effective Tax Rate | 119.44 |
Stock Price Statistics
VERBIO Vereinigte BioEnergie AG's stock has gained approximately 139.15757% over the past 52 weeks. The 50-day moving average sits at 35.07, while the 200-day moving average is 26.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | 139.15757% |
| 50-Day Moving Average | 35.07 |
| 200-Day Moving Average | 26.90 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, VERBIO Vereinigte BioEnergie AG generated 1.77B in revenue and converted that into -75.10M in net income, yielding earnings per share of -1.14. EBITDA reached -60.61M, while operating income came in at -60.61M.
| Revenue | 1.77B |
| Gross Profit | 279.93M |
| Operating Income | -60.61M |
| Pretax Income | -50.46M |
| Net Income | -75.10M |
| EBITDA | -60.61M |
| EBIT | -60.61M |
| Earnings Per Share (EPS) | -1.14 |
Balance Sheet
VERBIO Vereinigte BioEnergie AG holds 76.75M in cash and equivalents against 227.57M in total debt, resulting in a net debt position of 140.64M. Total book value stands at 283.68M, with working capital of 258.06M providing operational flexibility.
| Cash & Cash Equivalents | 76.75M |
| Total Debt | 227.57M |
| Net Debt | 140.64M |
| Equity (Book Value) | 283.68M |
| Book Value Per Share | 4.28 |
| Working Capital | 258.06M |
Cash Flow
VERBIO Vereinigte BioEnergie AG produced 121.79M in operating cash flow over the past twelve months. After subtracting -99.86M in capital expenditures, free cash flow totaled 21.92M - equivalent to 0.33 per share.
| Operating Cash Flow | 121.79M |
| Capital Expenditures | -99.86M |
| Free Cash Flow | 21.92M |
| FCF Per Share | 0.33 |
Margins
VERBIO Vereinigte BioEnergie AG operates with a gross margin of 15.78, reflecting its pricing power and cost economics. The operating margin of -3.42 and net profit margin of -4.23 provide insight into operational efficiency.
| Gross Margin | 15.78 |
| Operating Margin | -3.42 |
| Pretax Margin | -2.84 |
| Profit Margin | -4.23 |
| EBITDA Margin | -3.42 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.60 |
| FCF Yield | 7.31 |
Scores
VERBIO Vereinigte BioEnergie AG posts an Altman Z-Score of 5.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.14 |